195 related articles for article (PubMed ID: 16957031)
21. Rapid control of a hospital-wide outbreak caused by extensively drug-resistant OXA-72-producing Acinetobacter baumannii.
Lin WR; Lu PL; Siu LK; Chen TC; Lin CY; Hung CT; Chen YH
Kaohsiung J Med Sci; 2011 Jun; 27(6):207-14. PubMed ID: 21601165
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
[TBL] [Abstract][Full Text] [Related]
23. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
24. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118.
Manageiro V; Jones-Dias D; Ferreira E; Louro D; ; Caniça M
Int J Antimicrob Agents; 2012 Nov; 40(5):398-403. PubMed ID: 22890192
[TBL] [Abstract][Full Text] [Related]
25. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.
Dalla-Costa LM; Coelho JM; Souza HA; Castro ME; Stier CJ; Bragagnolo KL; Rea-Neto A; Penteado-Filho SR; Livermore DM; Woodford N
J Clin Microbiol; 2003 Jul; 41(7):3403-6. PubMed ID: 12843104
[TBL] [Abstract][Full Text] [Related]
26. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
27. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Wang H; Guo P; Sun H; Wang H; Yang Q; Chen M; Xu Y; Zhu Y
Antimicrob Agents Chemother; 2007 Nov; 51(11):4022-8. PubMed ID: 17846127
[TBL] [Abstract][Full Text] [Related]
28. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Peymani A; Higgins PG; Nahaei MR; Farajnia S; Seifert H
Int J Antimicrob Agents; 2012 Jun; 39(6):526-8. PubMed ID: 22521767
[TBL] [Abstract][Full Text] [Related]
29. Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.
Tiwari V; Kapil A; Moganty RR
Microb Pathog; 2012 Aug; 53(2):81-6. PubMed ID: 22610043
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital.
Kim JW; Heo ST; Jin JS; Choi CH; Lee YC; Jeong YG; Kim SJ; Lee JC
Clin Microbiol Infect; 2008 Jul; 14(7):716-8. PubMed ID: 18558945
[TBL] [Abstract][Full Text] [Related]
31. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
32. Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy.
Mendes RE; Spanu T; Deshpande L; Castanheira M; Jones RN; Fadda G
Clin Microbiol Infect; 2009 Jun; 15(6):588-92. PubMed ID: 19438644
[TBL] [Abstract][Full Text] [Related]
33. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
Jeong SH; Bae IK; Park KO; An YJ; Sohn SG; Jang SJ; Sung KH; Yang KS; Lee K; Young D; Lee SH
J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178
[TBL] [Abstract][Full Text] [Related]
34. Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece.
Wybo I; Blommaert L; De Beer T; Soetens O; De Regt J; Lacor P; Piérard D; Lauwers S
J Hosp Infect; 2007 Dec; 67(4):374-80. PubMed ID: 18023922
[TBL] [Abstract][Full Text] [Related]
35. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y
J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537
[TBL] [Abstract][Full Text] [Related]
36. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
Karah N; Giske CG; Sundsfjord A; Samuelsen Ø
Microb Drug Resist; 2011 Dec; 17(4):545-9. PubMed ID: 21830948
[TBL] [Abstract][Full Text] [Related]
37. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Amudhan SM; Sekar U; Arunagiri K; Sekar B
Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
[TBL] [Abstract][Full Text] [Related]
38. Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites.
Gur D; Korten V; Unal S; Deshpande LM; Castanheira M
J Med Microbiol; 2008 Dec; 57(Pt 12):1529-1532. PubMed ID: 19018025
[TBL] [Abstract][Full Text] [Related]
39. Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal.
Diene SM; Fall B; Kempf M; Fenollar F; Sow K; Niang B; Wade B; Raoult D; Rolain JM
Int J Infect Dis; 2013 Mar; 17(3):e209-10. PubMed ID: 23084970
[No Abstract] [Full Text] [Related]
40. High endemic rates of OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates caused by the persistence of major clones in hospitals in a Brazilian city 5 years after an outbreak.
Pagano M; Barin J; Martins AF; Zavascki AP
Infect Control Hosp Epidemiol; 2015 Jul; 36(7):860-2. PubMed ID: 25773462
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
